Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-11-08

Clinical Trial Update: The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating vilazodone's effect on glutamate in the anterior cingulate cortex for patients with anxious major depressive disorder has been withdr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vilazodone (vilazodone)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Major Depressive Disorder, Anxiety | Phase 4 | Status: WITHDRAWN